Teladoc Health, Inc.(TDOC)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Teladoc Health, Inc. (TDOC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TDOC at 40.8/100 on a 32-signal composite quality model, placing it at rank #2,088 of 2,960 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (18.5) and balance sheet strength (20.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 31.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Teladoc Health, Inc. reports quarterly revenue of $606.9M, net income of $-38.9M, an operating margin of -6.1%. Top institutional holders of TDOC by reported 13-F value include TENOR CAPITAL MANAGEMENT , L.P., D. E. Shaw, BlackRock, based on the most recent SEC filings. TDOC trades on the NYSE exchange and files with the SEC under CIK 1477449. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TDOC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Teladoc Health, Inc. directly from SEC EDGAR.